Background and literature
Patent filed: WO2020221937A1 Anti-GA efficacy in cellular models: https://www.embopress.org/doi/full/10.15252/emmm.201607054 (open access) …
About Intravacc
Intravacc, located at Utrecht Science Park Bilthoven in the Netherlands, is a leading global contract development and manufacturing organization (CDMO) of innovative vaccines…
GA-VAX
THE CHALLENGE
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease and the available drugs extend life by only a few months.
With a lifetime risk of about 1:500…
Curriculum Vitae
Degrees 2014 Habilitation, Ludwig-Maximilians-Universität München, Germany 2007 Dr. med. (summa cum laude), Ludwig-Maximilians-Universität…
The speech of patients with neurodegenerative diseases gradually changes. Thanks to the help of artificial intelligence, even the slightest changes can become the basis for a diagnosis.
The speech of…
Areas of investigation/research focus
Glia are essential for the function of the nervous system. We study how glial cells contribute to brain function and how their dysfunction leads to diseases.…
About 3.000 blood samples will be analyzed for a research network led by the DZNE.
A research network led by the DZNE is investigating whether blood tests can be used to diagnose and predict…
OBJECTIVES
The GA-VAX project will advance an exciting novel treatment modality for C9orf72 ALS towards clinical-readiness by rigorously evaluating all scientific, manufacturing, regulatory and…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
